CBD Selectively Dials Down Two Key Inflammation Signals in Human Immune Cells
In human monocytes activated through nine different immune pathways, CBD selectively suppressed two pro-inflammatory cytokines (IL-1β and IL-6) while leaving most other immune signals unaffected.
Quick Facts
What This Study Found
CBD (0.5-10 μM) significantly suppressed IL-1β secretion across most toll-like receptor pathways and modulated IL-6 production, while 11 other immune mediators remained largely unaffected, revealing a highly selective anti-inflammatory profile.
Key Numbers
CBD tested at 0.5-10 μM; 9 toll-like receptors tested; 13 immune mediators measured; significant suppression of IL-1β through most TLRs (except TLR3 and TLR8); significant modulation of IL-6 through most TLRs (except TLR1 and TLR3); 11 other mediators largely unaffected.
How They Did This
In vitro study treating human primary monocytes activated through each of nine toll-like receptors with CBD at multiple concentrations, measuring secretion of 13 immune mediators.
Why This Research Matters
The finding that CBD's anti-inflammatory effects are selective rather than broadly immunosuppressive helps explain why CBD may reduce inflammation without the widespread immune suppression seen with conventional anti-inflammatory drugs.
The Bigger Picture
As CBD products are widely consumed by the public, understanding exactly which immune pathways CBD affects in human cells provides essential foundational data for evaluating both therapeutic potential and safety concerns.
What This Study Doesn't Tell Us
In vitro study may not reflect in vivo effects; CBD concentrations tested may not correspond to levels achievable through oral consumption; monocytes are only one component of the immune system.
Questions This Raises
- ?Do these selective anti-inflammatory effects translate to measurable clinical benefits in people with inflammatory conditions?
- ?What CBD blood levels are needed to achieve the concentrations tested?
Trust & Context
- Key Stat:
- CBD selectively suppressed IL-1β and IL-6 while leaving 11 other immune mediators unaffected
- Evidence Grade:
- In vitro study using human primary cells provides preliminary mechanistic evidence requiring clinical validation.
- Study Age:
- Published in 2021.
- Original Title:
- Cannabidiol selectively modulates interleukin (IL)-1β and IL-6 production in toll-like receptor activated human peripheral blood monocytes.
- Published In:
- Toxicology, 464, 153016 (2021)
- Authors:
- Sermet, Sera(3), Li, Jinpeng(2), Bach, Anthony(2), Crawford, Robert B, Kaminski, Norbert E
- Database ID:
- RTHC-03512
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Does CBD suppress the whole immune system?
No. This study found CBD selectively reduced only two of 13 immune signals tested (IL-1β and IL-6), suggesting a targeted anti-inflammatory effect rather than broad immune suppression.
Why do IL-1β and IL-6 matter?
Both are pro-inflammatory cytokines involved in many inflammatory diseases. IL-6 plays roles in conditions from rheumatoid arthritis to COVID-19 cytokine storms, making selective suppression therapeutically interesting.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-03512APA
Sermet, Sera; Li, Jinpeng; Bach, Anthony; Crawford, Robert B; Kaminski, Norbert E. (2021). Cannabidiol selectively modulates interleukin (IL)-1β and IL-6 production in toll-like receptor activated human peripheral blood monocytes.. Toxicology, 464, 153016. https://doi.org/10.1016/j.tox.2021.153016
MLA
Sermet, Sera, et al. "Cannabidiol selectively modulates interleukin (IL)-1β and IL-6 production in toll-like receptor activated human peripheral blood monocytes.." Toxicology, 2021. https://doi.org/10.1016/j.tox.2021.153016
RethinkTHC
RethinkTHC Research Database. "Cannabidiol selectively modulates interleukin (IL)-1β and IL..." RTHC-03512. Retrieved from https://rethinkthc.com/research/sermet-2021-cannabidiol-selectively-modulates-interleukin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.